Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
560.95
553.71
440.69
430.84
348.29
318.86
306.47
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
560.95
553.71
440.69
430.84
348.29
318.86
306.47
Raw Material Cost
304.16
321.13
261.55
255.55
179.07
148.56
149.80
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.94
0.57
0.77
1.41
0.44
0.05
0.09
Selling and Distribution Expenses
52.88
63.82
60.60
77.87
46.73
43.90
41.88
Other Expenses
4.07
4.34
3.47
2.82
2.83
1.86
1.69
Total Expenditure (Excl Depreciation)
399.66
428.91
357.61
363.05
254.54
211.09
208.65
Operating Profit (PBDIT) excl Other Income
161.29999999999998
124.80000000000001
83.10000000000001
67.8
93.69999999999999
107.8
97.8
Other Income
30.09
36.32
37.19
63.92
56.92
56.72
51.40
Operating Profit (PBDIT)
233.25
197.86
155.56
151.71
177.03
183.07
169.88
Interest
1.94
0.57
0.77
1.41
0.44
0.05
0.09
Exceptional Items
-4.47
0.27
-2.64
-37.80
0.99
3.02
0.00
Gross Profit (PBDT)
256.79
232.59
179.14
175.29
169.22
170.30
156.67
Depreciation
63.63
58.49
50.07
27.58
24.04
26.01
28.98
Profit Before Tax
163.21
139.07
102.08
84.93
153.54
160.02
140.82
Tax
23.00
19.69
13.63
16.56
20.77
22.80
20.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
143.72
124.21
91.37
64.37
128.58
130.59
118.17
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
143.72
124.21
91.37
64.37
128.58
130.59
118.17
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-4.43
-4.08
-5.01
-2.79
2.72
4.35
1.58
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
139.29
120.13
86.37
61.58
131.29
134.94
119.75
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,634.06
1,556.09
1,476.35
1,418.93
1,381.02
1,317.93
1,248.34
Earnings per share (EPS)
0.86
0.74
0.54
0.38
0.77
0.78
0.7
Diluted Earnings per share
0.86
0.74
0.54
0.38
0.77
0.78
0.7
Operating Profit Margin (Excl OI)
24.87%
18.61%
15.5%
13.97%
27.58%
31.47%
29.2%
Gross Profit Margin
40.44%
35.68%
34.53%
26.11%
50.99%
58.34%
55.4%
PAT Margin
25.62%
22.43%
20.73%
14.94%
36.92%
40.95%
38.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 1.32% vs 25.64% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 15.99% vs 39.00% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 25.82% vs 36.40% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 216.67% vs -25.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Cabio Biotech (Wuhan) Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
560.95
0
560.95
Other Operating Income
0.00
0.00
0.00
Total Operating income
560.95
0
560.95
Raw Material Cost
304.16
0
304.16
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.94
0
1.94
Selling and Distribution Expenses
52.88
0
52.88
Other Expenses
4.07
0.00
4.07
Total Expenditure (Excl Depreciation)
399.66
0
399.66
Operating Profit (PBDIT) excl Other Income
161.29
0.00
161.29
Other Income
30.09
0
30.09
Operating Profit (PBDIT)
233.25
0
233.25
Interest
1.94
0
1.94
Exceptional Items
-4.47
0
-4.47
Gross Profit (PBDT)
256.79
0
256.79
Depreciation
63.63
0
63.63
Profit Before Tax
163.21
0
163.21
Tax
23.00
0
23.00
Provisions and contingencies
0
0
0.00
Profit After Tax
143.72
0
143.72
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
143.72
0
143.72
Share in Profit of Associates
0
0
0.00
Minority Interest
-4.43
0
-4.43
Other related items
0.00
0.00
0.00
Consolidated Net Profit
139.29
0
139.29
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,634.06
0
1,634.06
Earnings per share (EPS)
0.86
0
0.86
Diluted Earnings per share
0.86
0
0.86
Operating Profit Margin (Excl OI)
24.87%
0%
0.00
24.87%
Gross Profit Margin
40.44%
0%
0.00
40.44%
PAT Margin
25.62%
0%
0.00
25.62%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 56.10 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 1.32% vs 25.64% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 13.93 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 15.99% vs 39.00% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.32 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 25.82% vs 36.40% in Dec 2024
Annual - Interest
Interest 0.19 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 216.67% vs -25.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.87%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






